{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:06:37Z","timestamp":1789675597029,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773980"],"award-info":[{"award-number":["81773980"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["15401902600"],"award-info":[{"award-number":["15401902600"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Integrative Medicine"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.joim.2024.03.006","type":"journal-article","created":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T03:47:24Z","timestamp":1709956044000},"page":"188-198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Danhongqing formula alleviates cholestatic liver fibrosis by downregulating long non-coding RNA H19 derived from cholangiocytes and inhibiting hepatic stellate cell activation"],"prefix":"10.1016","volume":"22","author":[{"given":"Meng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lie-ming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Ping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.joim.2024.03.006_b0005","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41395-018-0390-3","article-title":"Diagnosis and management of primary biliary cholangitis","volume":"114","author":"Younossi","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.joim.2024.03.006_b0010","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines: management of cholestatic liver diseases. J Hepatol 2009; 51(2): 237\u201367.","DOI":"10.1016\/j.jhep.2009.04.009"},{"issue":"28","key":"10.1016\/j.joim.2024.03.006_b0015","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.3748\/wjg.v20.i28.9418","article-title":"Atypical causes of cholestasis","volume":"20","author":"Nguyen","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.joim.2024.03.006_b0020","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00424-006-0062-9","article-title":"Function and pathophysiological importance of ABCB4 (MDR3 p-glycoprotein)","volume":"453","author":"Oude Elferink","year":"2007","journal-title":"Pflugers Arch"},{"issue":"1","key":"10.1016\/j.joim.2024.03.006_b0025","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1172\/JCI117658","article-title":"Regulation of biliary lipid secretion by mdr2 p-glycoprotein in the mouse","volume":"95","author":"Oude Elferink","year":"1995","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.joim.2024.03.006_b0030","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0092-8674(93)90380-9","article-title":"Homozygous disruption of the murine Mdr2 p-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease","volume":"75","author":"Smit","year":"1993","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.joim.2024.03.006_b0035","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jhep.2005.06.025","article-title":"Mdr2 (Abcb4)-\/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro-and antifibrogenic genes","volume":"43","author":"Popov","year":"2005","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.joim.2024.03.006_b0040","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jhep.2012.01.029","article-title":"STAT proteins-key regulators of anti-viral responses, inflammation, and tumorigenesis in the liver","volume":"57","author":"Gao","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.joim.2024.03.006_b0045","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7159592","article-title":"Long noncoding RNAs in pathological cardiac remodeling: a review of the update literature","volume":"2019","author":"Zhou","year":"2019","journal-title":"Biomed Res Int"},{"issue":"2","key":"10.1016\/j.joim.2024.03.006_b0050","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.canlet.2013.06.013","article-title":"Long non-coding RNAs: a new frontier in the study of human diseases","volume":"339","author":"Shi","year":"2013","journal-title":"Cancer Lett"},{"issue":"3","key":"10.1016\/j.joim.2024.03.006_b0055","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1002\/hep.31765","article-title":"Long noncoding RNA H19: a key player in liver diseases","volume":"74","author":"Wang","year":"2021","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.joim.2024.03.006_b0060","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.3390\/ijms21041482","article-title":"The roles and mechanisms of lncRNAs in liver fibrosis","volume":"21","author":"He","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.joim.2024.03.006_b0065","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3390\/cells9010190","article-title":"Cholangiocyte-derived exosomal lncRNA H19 promotes macrophage activation and hepatic inflammation under cholestatic conditions","volume":"9","author":"Li","year":"2020","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.joim.2024.03.006_b0070","first-page":"56","article-title":"Screening and verification on prescription of Chinese herbal monomers for anti-liver fibrosis based on uniform design","volume":"33","author":"Zhu","year":"2019","journal-title":"Shanghai Zhong Yi Yao Da Xue Xue Bao"},{"issue":"1","key":"10.1016\/j.joim.2024.03.006_b0075","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/HEP.0000000000000317","article-title":"P4HA2 induces hepatic ductular reaction and biliary fibrosis in chronic cholestatic liver diseases","volume":"78","author":"Zhang","year":"2023","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.joim.2024.03.006_b0080","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1194\/jlr.M088070","article-title":"Hydrophilic bile acids prevent liver damage caused by lack of biliary phospholipid in Mdr2-\/- mice","volume":"60","author":"Wang","year":"2019","journal-title":"J Lipid Res"},{"issue":"2","key":"10.1016\/j.joim.2024.03.006_b0085","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/hep.28965","article-title":"The ascending pathophysiology of cholestatic liver disease","volume":"65","author":"Jansen","year":"2017","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.joim.2024.03.006_b0090","doi-asserted-by":"crossref","first-page":"e22094","DOI":"10.1371\/journal.pone.0022094","article-title":"Profiling circulating and urinary bile acids in patients with biliary obstruction before and after biliary stenting","volume":"6","author":"Trottier","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.joim.2024.03.006_b0095","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ajg.2009.633","article-title":"Longitudinal profiles of 15 serum bile acids in patients with intrahepatic cholestasis of pregnancy","volume":"105","author":"Tribe","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.joim.2024.03.006_b0100","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0168-8278(97)80020-7","article-title":"The role of bile salt composition in liver pathology of Mdr2-\/- mice: differences between males and females","volume":"26","author":"van Nieuwerk","year":"1997","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.joim.2024.03.006_b0105","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/hep.24711","article-title":"Induction of heme oxygenase 1 prevents progression of liver fibrosis in Mdr2 knockout mice","volume":"55","author":"Barikbin","year":"2012","journal-title":"Hepatology"},{"issue":"1 Suppl","key":"10.1016\/j.joim.2024.03.006_b0110","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.jhep.2015.02.039","article-title":"Hepatic fibrosis: concept to treatment","volume":"62","author":"Trautwein","year":"2015","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.joim.2024.03.006_b0115","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/hep.30150","article-title":"Ductular reaction in liver diseases: pathological mechanisms and translational significances","volume":"69","author":"Sato","year":"2019","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.joim.2024.03.006_b0120","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.jhep.2011.09.022","article-title":"Development of the bile ducts: essentials for the clinical hepatologist","volume":"56","author":"Strazzabosco","year":"2012","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.joim.2024.03.006_b0125","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1055\/s-0031-1272832","article-title":"Epithelial-mesenchymal interactions in biliary diseases","volume":"31","author":"Fabris","year":"2011","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.joim.2024.03.006_b0130","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.trsl.2020.11.010","article-title":"Long non-coding RNA H19\u2014a new player in the pathogenesis of liver diseases","volume":"230","author":"Yang","year":"2021","journal-title":"Transl Res"},{"issue":"5","key":"10.1016\/j.joim.2024.03.006_b0135","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1002\/hep.30698","article-title":"Long noncoding RNA H19 contributes to cholangiocyte proliferation and cholestatic liver fibrosis in biliary atresia","volume":"70","author":"Xiao","year":"2019","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.joim.2024.03.006_b0140","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/hep.29145","article-title":"The role of long noncoding RNA H19 in gender disparity of cholestatic liver injury in multidrug resistance 2 gene knockout mice","volume":"66","author":"Li","year":"2017","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.joim.2024.03.006_b0145","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.30662","article-title":"Cholangiocyte-derived exosomal long noncoding RNA H19 promotes hepatic stellate cell activation and cholestatic liver fibrosis","volume":"70","author":"Liu","year":"2019","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.joim.2024.03.006_b0150","doi-asserted-by":"crossref","first-page":"e176173","DOI":"10.1371\/journal.pone.0176173","article-title":"Both MAPK and STAT3 signal transduction pathways are necessary for IL-6-dependent hepatic stellate cells activation","volume":"12","author":"Kagan","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.joim.2024.03.006_b0155","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/s41467-017-01236-6","article-title":"Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis","volume":"8","author":"Chakraborty","year":"2017","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.joim.2024.03.006_b0160","doi-asserted-by":"crossref","first-page":"14090","DOI":"10.1038\/s41598-018-32497-w","article-title":"Astaxanthin alleviated ethanol-induced liver injury by inhibition of oxidative stress and inflammatory responses via blocking of STAT3 activity","volume":"8","author":"Han","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.joim.2024.03.006_b0165","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/cvr\/cvy206","article-title":"Long non-coding RNA H19 regulates endothelial cell aging via inhibition of STAT3 signalling","volume":"115","author":"Hofmann","year":"2019","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.joim.2024.03.006_b0170","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.biocel.2019.05.011","article-title":"LncRNA H19 promotes epithelial mesenchymal transition and metastasis of esophageal cancer via STAT3\/EZH2 axis","volume":"113","author":"Chen","year":"2019","journal-title":"Int J Biochem Cell Biol"},{"issue":"3","key":"10.1016\/j.joim.2024.03.006_b0175","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.joim.2020.03.001","article-title":"Guidelines for diagnosis and treatment of hepatic fibrosis with integrated traditional Chinese and Western medicine (2019 edition)","volume":"18","author":"Xu","year":"2020","journal-title":"J Integr Med"},{"key":"10.1016\/j.joim.2024.03.006_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.112687","article-title":"Compound-based Chinese medicine formula: from discovery to compatibility mechanism","volume":"254","author":"Luan","year":"2020","journal-title":"J Ethnopharmacol"}],"container-title":["Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S209549642400030X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S209549642400030X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T16:29:25Z","timestamp":1713457765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S209549642400030X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S209549642400030X"],"URL":"https:\/\/doi.org\/10.1016\/j.joim.2024.03.006","relation":{},"ISSN":["2095-4964"],"issn-type":[{"value":"2095-4964","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Danhongqing formula alleviates cholestatic liver fibrosis by downregulating long non-coding RNA H19 derived from cholangiocytes and inhibiting hepatic stellate cell activation","name":"articletitle","label":"Article Title"},{"value":"Journal of Integrative Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joim.2024.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Shanghai Yueyang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. All rights reserved.","name":"copyright","label":"Copyright"}]}}